Other studies with TS inhibitors have also reported differential effects on [18F]FLT uptake in tumor and normal proliferating tissues, suggesting that bone marrow may respond differently to TS inhibitors than tumor cells [37]. The gene discussed is TYMS; the disease is neoplasm.